Cargando…
Cell and Animal Models for SARS-CoV-2 Research
During the last two years following the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, development of potent antiviral drugs and vaccines has been a global health priority. In this context, the understanding of virus pathophysiology, the identification of associated therapeut...
Autores principales: | Bestion, Eloïne, Halfon, Philippe, Mezouar, Soraya, Mège, Jean-Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319816/ https://www.ncbi.nlm.nih.gov/pubmed/35891487 http://dx.doi.org/10.3390/v14071507 |
Ejemplares similares
-
Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint Inhibitors
por: Bestion, Eloïne, et al.
Publicado: (2023) -
GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition
por: Bestion, Eloïne, et al.
Publicado: (2022) -
Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives
por: Toumi, Eya, et al.
Publicado: (2023) -
Daytime variation in SARS-CoV-2 infection and cytokine production
por: Diallo, Aïssatou Bailo, et al.
Publicado: (2021) -
Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines
por: Vitte, Joana, et al.
Publicado: (2020)